Search Results 1571-1580 of 17842 for Substance+dependence

  1. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

    ... drug-drug interaction with dabrafenib. Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2;; Must have adequate organ function as defined by ...

  2. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

    ... drug is stopped; All patients must be willing and able to give written informed consent. Exclusion Criteria. Clinical stage III or IV disease; Autoimmune ...

  3. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

    ... drug or that may affect the interpretation of the results or render the patient at high risk from treatment complications;; Active tuberculosis;; Active ...

  4. A Study To Investigate The Efficacy And Safety Of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib In Adults With Relapsed/Refractory Mantle Cell Lymphoma - Mayo Clinic

    ... drug * Prior allogeneic stem cell transplant within 6 months of the first dose of the study drug * Known central nervous system involvement by lymphoma * ...

  5. MCM How genetics factor into treating alcohol use disorder SCRIPT

    are suffering from other substance use disorders.” Dr. Victor Karpyak, who oversees Mayo. Clinic's addiction treatment services, says about half of those ...

  6. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

    Participation in another investigational drug study within 1 year of treatment. Laboratory Exclusion Criteria: Serum 25-hydroxyvitamin D < 15 ng/ml. Serum ...

  7. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

    About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.

  8. Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer - Mayo Clinic

    ... drug administration; Has received TAS-102; Has unresolved toxicity of greater than or equal to CTCAE Grade 2 attributed to any prior therapies; Is a pregnant ...

  9. Deep brain stimulation - Doctors & Departments - Mayo Clinic

    Deep brain stimulation in drug addiction treatment: Research progress and perspective. Frontiers in Psychiatry. 2022; doi:10.3389/fpsyt.2022.858638. Medical ...

  10. Publications - Xi Zhang, M.D., Ph.D. - Mayo Clinic

    The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev Cell. 2013 Apr 29; 25 (2):156-68. View PubMed. PST-20589525. Home ...